JPWO2020054788A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020054788A5
JPWO2020054788A5 JP2020546064A JP2020546064A JPWO2020054788A5 JP WO2020054788 A5 JPWO2020054788 A5 JP WO2020054788A5 JP 2020546064 A JP2020546064 A JP 2020546064A JP 2020546064 A JP2020546064 A JP 2020546064A JP WO2020054788 A5 JPWO2020054788 A5 JP WO2020054788A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen atom
group
acceptable salt
pharmacologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020546064A
Other languages
English (en)
Japanese (ja)
Other versions
JP7458987B2 (ja
JPWO2020054788A1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/035792 external-priority patent/WO2020054788A1/ja
Publication of JPWO2020054788A1 publication Critical patent/JPWO2020054788A1/ja
Publication of JPWO2020054788A5 publication Critical patent/JPWO2020054788A5/ja
Application granted granted Critical
Publication of JP7458987B2 publication Critical patent/JP7458987B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020546064A 2018-09-13 2019-09-12 イミダゾピリジノン化合物 Active JP7458987B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018171839 2018-09-13
JP2018171839 2018-09-13
PCT/JP2019/035792 WO2020054788A1 (ja) 2018-09-13 2019-09-12 イミダゾピリジノン化合物

Publications (3)

Publication Number Publication Date
JPWO2020054788A1 JPWO2020054788A1 (ja) 2021-08-30
JPWO2020054788A5 true JPWO2020054788A5 (https=) 2022-09-14
JP7458987B2 JP7458987B2 (ja) 2024-04-01

Family

ID=69777067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020546064A Active JP7458987B2 (ja) 2018-09-13 2019-09-12 イミダゾピリジノン化合物

Country Status (24)

Country Link
US (2) US12077531B2 (https=)
EP (1) EP3808747B1 (https=)
JP (1) JP7458987B2 (https=)
KR (1) KR102830577B1 (https=)
CN (1) CN112689637B (https=)
AR (1) AR116400A1 (https=)
AU (1) AU2019340173B2 (https=)
BR (1) BR112021004730A2 (https=)
CA (1) CA3106385A1 (https=)
DK (1) DK3808747T3 (https=)
ES (1) ES3016010T3 (https=)
FI (1) FI3808747T3 (https=)
HU (1) HUE069830T2 (https=)
IL (1) IL281391B2 (https=)
MX (1) MX2021003027A (https=)
MY (1) MY207239A (https=)
NZ (1) NZ773786A (https=)
PH (1) PH12021550512A1 (https=)
PL (1) PL3808747T3 (https=)
PT (1) PT3808747T (https=)
SG (1) SG11202102441VA (https=)
TW (1) TWI814903B (https=)
WO (1) WO2020054788A1 (https=)
ZA (1) ZA202101671B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7414550B2 (ja) * 2020-01-23 2024-01-16 キッセイ薬品工業株式会社 (ヘテロ)アリールイミダゾロン化合物
WO2021174024A1 (en) 2020-02-28 2021-09-02 First Wave Bio, Inc. Methods of treating iatrogenic autoimmune colitis
KR20220152276A (ko) * 2020-03-11 2022-11-15 깃세이 야쿠힌 고교 가부시키가이샤 이미다조피리디논 화합물 또는 그 염의 결정
JP7654426B2 (ja) * 2020-03-12 2025-04-01 キッセイ薬品工業株式会社 イミダゾピリジノン化合物の製造方法
CN117402178B (zh) * 2023-12-15 2024-03-08 英矽智能科技(上海)有限公司 作为jak抑制剂和phd抑制剂的嘧啶类化合物
WO2025264818A1 (en) * 2024-06-20 2025-12-26 Raythera, Inc. Stat6 modulators and methods of uses thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0650961T3 (da) * 1993-11-02 1997-09-15 Hoechst Ag Substituerede heterocykliske carboxylsyreamider, deres fremstilling og deres anvendelse som lægemidler.
ID29028A (id) 1998-09-18 2001-07-26 Basf Ag Pirolopirimidina sebagai penghambat protein kinase
US6713474B2 (en) 1998-09-18 2004-03-30 Abbott Gmbh & Co. Kg Pyrrolopyrimidines as therapeutic agents
AU2000240570A1 (en) 2000-03-29 2001-10-08 Knoll Gesellschaft Mit Beschraenkter Haftung Pyrrolopyrimidines as tyrosine kinase inhibitors
CA2465328C (en) 2001-11-01 2011-06-14 Michael Francis Gross Piperidines
WO2005010003A1 (en) * 2003-07-23 2005-02-03 Wyeth Sulfonyldihydroimid- azopyridinone compounds as 5-hydroxytryptamine-6 ligands
WO2005023761A2 (en) 2003-09-11 2005-03-17 Kemia, Inc. Cytokine inhibitors
CA2565599C (en) * 2004-05-18 2012-07-31 Schering Corporation Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
CA2601458C (en) 2005-03-15 2011-04-26 Pfizer Inc. Benzimidazolone derivatives as cb2 receptor ligands
DE102005019712A1 (de) * 2005-04-28 2006-11-09 Bayer Healthcare Ag Dipyridyl-dihydropyrazolone und ihre Verwendung
WO2007015877A2 (en) * 2005-07-20 2007-02-08 Kalypsys, Inc. Inhibitors of p38 kinase and methods of treating inflammatory disorders
EP1965862A2 (en) * 2005-12-21 2008-09-10 Schering Corporation Combination of an h3 antagonist/inverse agonist and an appetite suppressant
US20090298811A1 (en) 2006-09-12 2009-12-03 Pfizer Inc Benzimidazolone derivatives
US8309544B2 (en) 2007-05-16 2012-11-13 Merck Sharp & Dohme Corp. Spiroindalones
JP2010527999A (ja) * 2007-05-23 2010-08-19 フアーマコペイア・エル・エル・シー PKC−θ阻害剤としてのプリノン類および1H−イミダゾピリジノン類
JP2010537998A (ja) 2007-08-27 2010-12-09 ワイス・エルエルシー イミダゾピリジン類似体、およびWnt−βカテニン細胞メッセージ伝達系のアゴニストとしてのその使用
CA2716798A1 (en) * 2008-02-25 2009-09-03 Merck Sharp & Dohme Corp. Tetrahydrofuropyridones
PT2294066E (pt) 2008-04-28 2014-11-21 Janssen Pharmaceutica Nv Benzoimidazoles como inibidores da prolil-hidroxilase
CA2719234A1 (en) * 2008-05-08 2009-11-12 Joan M. Fletcher Spiroazaindoles
US9062056B2 (en) * 2008-09-09 2015-06-23 Boehringer Ingelheim International Gmbh Aza-benzimidazolone Chymase inhibitors
EP3594213A1 (en) * 2009-07-17 2020-01-15 Japan Tobacco Inc. Triazolopyridine compounds and action thereof as prolyl hydroxylase inhibitors and erythropoietin production inducers
JP2011037814A (ja) 2009-08-14 2011-02-24 Synstar Japan Co Ltd マラリア原虫疾患予防又は治療用の5−ヘテロ環置換イミノ−9−ジアルキルアミノベンゾ[a]フェノキサチン化合物又はその塩とアーテミシニン誘導体との組み合わせ
WO2011096490A1 (ja) 2010-02-04 2011-08-11 第一三共株式会社 イミダゾピリジン-2-オン誘導体
FR2967355B1 (fr) * 2010-11-17 2013-09-27 Jouvin Jean Luc Seringue dentaire securisee
WO2014181813A1 (ja) 2013-05-10 2014-11-13 武田薬品工業株式会社 複素環化合物
WO2015052765A1 (ja) 2013-10-08 2015-04-16 日立マクセル株式会社 投射型映像表示装置、操作検出装置及び投射型映像表示方法
SG11201604755QA (en) * 2013-10-10 2016-07-28 Glenmark Pharmaceuticals Sa Substituted dihydro-benzimidazole compounds as ror gamma modulators
CN104926733B (zh) 2014-03-18 2019-05-10 北京韩美药品有限公司 作为RORγ调节剂的化合物
GB201504565D0 (en) * 2015-03-18 2015-05-06 Takeda Pharmaceutical Novel compounds
UA124090C2 (uk) * 2015-06-03 2021-07-21 Прінсіпіа Байофарма Інк. Інгібітори тирозинкінази
EP3414234B1 (en) * 2015-10-14 2022-06-29 Zibo Biopolar Changsheng Pharmaceutical Co. Ltd. Bruton's tyrosine kinase inhibitors
AU2017317123B9 (en) 2016-08-22 2021-11-25 Medshine Discovery Inc. PDE4 inhibitor
AU2017326006B2 (en) * 2016-09-16 2021-10-28 Vitae Pharmaceuticals, LLC. Inhibitors of the menin-MLL interaction
WO2019141803A1 (en) * 2018-01-19 2019-07-25 Idorsia Pharmaceuticals Ltd C5a receptor modulators

Similar Documents

Publication Publication Date Title
JPWO2020054788A5 (https=)
JP2019514874A5 (https=)
JP2019104748A5 (https=)
JP2017537940A5 (https=)
JP2016520618A5 (https=)
JP2016540742A5 (https=)
JP2010504286A5 (https=)
JP2016518437A5 (https=)
JP2015143283A5 (https=)
JP2012524056A5 (https=)
JP2015522650A5 (https=)
JP2016501250A5 (https=)
JP2013542218A5 (https=)
JP2013543842A5 (https=)
JP2010510999A5 (https=)
JP2008525417A5 (https=)
JP2010155827A5 (https=)
JP2010501478A5 (https=)
JP2018528244A5 (https=)
JP2018537535A5 (https=)
JP2019512535A5 (https=)
JP2020511547A5 (https=)
JP2020504434A5 (https=)
JP2016512547A5 (https=)
JP2015535847A5 (https=)